MAIA Biotechnology, Inc. (MAIA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

MAIA Biotechnology, Inc. (MAIA) closed at USD 1.12 on 2026-10-14, a change of -20 % over the past year, with a market capitalization of USD 69.15M.

MAIA Biotechnology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MAIA Biotechnology, Inc. key figures

Previous close

USD 1.12 (2026-10-14)

1-year change

-20 %

Market cap

USD 69.15M

Enterprise value

USD 40.53M

P/E ratio (trailing)

-1.87

P/E ratio (forward)

1.01

EPS (trailing)

-0.60

EPS (forward)

1.11

PEG ratio

n/a

Price to book

3.29

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.06

Employees

13

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MAIA Biotechnology, Inc. and compare it with other stocks.